Last updated on March 2019

A Phase 3 Study of S5G4T-1 in the Treatment of Papulopustular Rosacea


Brief description of study

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of S5G4T-1 for the treatment of moderate to severe papulopustular rosacea in adults.

All enrolled subjects will receive a topical gel to be applied once daily for 12 weeks. There are 6 in-office visits throughout the study and can include a physical exam, urine sampling, and assessments by qualified professionals and other assessments which will be reviewed in detail at your screening visit. All services are provided at no cost.

 

Clinical Study Identifier: TX216164

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.